Css LLC Chemo Centryx, Inc. Transaction History

Css LLC

$999 Million
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	BUY	$22.22 - $39.12 $75,992 - $133,790	3,420 Added 36.03%	12,912 $324,000
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $765,361 - $1.69 Million	-41,641 Reduced 81.44%	9,492 $346,000
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $507,864 - $764,109	38,533 Added 305.82%	51,133 $874,000
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $64,320 - $341,252	6,707 Added 113.81%	12,600 $169,000
Q3 2020 Nov 16, 2020	BUY	$46.35 - $61.69 $273,140 - $363,539	5,893 New	5,893 $323,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.